Preventive effect of aspirin on peripherally inserted central catheter-related vein thrombosis in patients with malignant tumors

IF 16.4 1区 化学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Caiyan Yu , Shaohua Sun , Xiuqing Shi, Li Wang, Qian Zhang, Lin Zhang , Dehua Song
{"title":"Preventive effect of aspirin on peripherally inserted central catheter-related vein thrombosis in patients with malignant tumors","authors":"Caiyan Yu ,&nbsp;Shaohua Sun ,&nbsp;Xiuqing Shi,&nbsp;Li Wang,&nbsp;Qian Zhang,&nbsp;Lin Zhang ,&nbsp;Dehua Song","doi":"10.1016/j.jvn.2023.06.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Abstract</h3><p>The majority of patients receiving chemotherapy undergo PICC catheterization. However, PICCs are significantly associated with catheter related complications, including deep vein thrombosis, blood infection, fibrin sheath, catheter prolapse, catheter displacement and blockage. Of all the risks, PICC-related VT was the most prevailing clinic symptom and resulted in a high risk of death.</p></div><div><h3>Aim</h3><p>The study aimed to investigate the preventive efficacy and safety of aspirin for patients with malignant tumors receiving venous thrombosis (VT) related with peripherally inserted central catheters (PICC) treatment.</p></div><div><h3>Patients and Methods</h3><p>A randomized controlled trial was conducted. Participants with malignant tumors receiving chemotherapy who accepted PICC insertion operation were randomly allocated to the aspirin treatment group (<em>n</em> = 235) or the control group (<em>n</em> = 246). The patients in the aspirin group were administrated aspirin (100mg) for 30 days, whereas the patients in control group were administrated a placebo drug. The incidence of PICC-related VT in both groups and the aspirin related adverse effects were evaluated.</p></div><div><h3>Results</h3><p>The incidence of PICC-related VT was 0.4% in the aspirin group, compared with 3.3% in the control group (<em>P</em> = 0.038). In addition, aspirin related bleeding was not observed.</p></div><div><h3>Conclusion</h3><p>PICC-related VT could be effectively prevented by aspirin in patients with malignant tumors.</p></div>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S106203032300047X","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

The majority of patients receiving chemotherapy undergo PICC catheterization. However, PICCs are significantly associated with catheter related complications, including deep vein thrombosis, blood infection, fibrin sheath, catheter prolapse, catheter displacement and blockage. Of all the risks, PICC-related VT was the most prevailing clinic symptom and resulted in a high risk of death.

Aim

The study aimed to investigate the preventive efficacy and safety of aspirin for patients with malignant tumors receiving venous thrombosis (VT) related with peripherally inserted central catheters (PICC) treatment.

Patients and Methods

A randomized controlled trial was conducted. Participants with malignant tumors receiving chemotherapy who accepted PICC insertion operation were randomly allocated to the aspirin treatment group (n = 235) or the control group (n = 246). The patients in the aspirin group were administrated aspirin (100mg) for 30 days, whereas the patients in control group were administrated a placebo drug. The incidence of PICC-related VT in both groups and the aspirin related adverse effects were evaluated.

Results

The incidence of PICC-related VT was 0.4% in the aspirin group, compared with 3.3% in the control group (P = 0.038). In addition, aspirin related bleeding was not observed.

Conclusion

PICC-related VT could be effectively prevented by aspirin in patients with malignant tumors.

阿司匹林对恶性肿瘤患者外周置入中央导管相关静脉血栓形成的预防作用
摘要 大多数接受化疗的患者都要进行 PICC 导管置管。然而,PICC 与导管相关并发症密切相关,包括深静脉血栓、血液感染、纤维蛋白鞘、导管脱垂、导管移位和堵塞。该研究旨在探讨阿司匹林对接受外周置入中心导管(PICC)治疗的静脉血栓(VT)相关恶性肿瘤患者的预防效果和安全性。接受 PICC 插管手术的恶性肿瘤化疗患者被随机分配到阿司匹林治疗组(235 人)或对照组(246 人)。阿司匹林治疗组患者服用阿司匹林(100 毫克)30 天,而对照组患者服用安慰剂。结果 阿司匹林组与 PICC 相关的 VT 发生率为 0.4%,而对照组为 3.3%(P = 0.038)。结论阿司匹林可有效预防恶性肿瘤患者的 PICC 相关 VT。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Accounts of Chemical Research
Accounts of Chemical Research 化学-化学综合
CiteScore
31.40
自引率
1.10%
发文量
312
审稿时长
2 months
期刊介绍: Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信